INMD is getting interesting in the mid 20s. They had projected a 2H slowdown in growth and the stock price is beginning to fully reflect that. The Hamas attack on Isreal isn't helping today, but I saw this comment posted on twitter from a reliable source:
Jefferies defended $INMD ,
spoke to management of the company in Israel,
INMD has just 1% of sales in Israel.
Plus, while it manufactures in the region, its plants are away from the conflict and operating normally. INMD carries safety stock with inventories of components for ~3 quarters.
----------
The key will be when do investors pivot and focus on FY24 prospects? They have a poor presentation of non-GAAP earnings (IMHO), but their balance sheet is quite strong. I think FV for the stock is in the 33-35 range, but the catalysts may not show up until after Q4.
News 
Market Data 
Discover 
